John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Bunge Global
BG
$21.2B
| $657K | ﹤0.01% |
7,977
-611,792
| -99% | -$52.2M |
|
1827
PUT
Sempra
SRE
$55.3B
| $654K | ﹤0.01% |
+12,000
| New | +$661K |
|
|
IPCM
1828
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $654K | ﹤0.01% |
14,017
-78,283
| -85% | -$3.41M |
|
1829
CALL
Macy's
M
$6.1B
| $649K | ﹤0.01% |
+10,000
| New | +$644K |
|
1830
Vanguard Morningstar Growth ETF
VUG
$224B
| $649K | ﹤0.01% |
+37,200
| New | +$660K |
|
1831
PUT
Healthpeak Properties
DOC
$14.9B
| $648K | ﹤0.01% |
+16,470
| New | +$661K |
|
|
AUO
1832
DELISTED
AU Optronics Corp
AUO
| $648K | ﹤0.01% |
129,355
-152,607
| -54% | -$816K |
|
|
OPB
1833
DELISTED
Opus Bank Common Stock
OPB
| $647K | ﹤0.01% |
+20,950
| New | +$593K |
|
|
LMOS
1834
DELISTED
Lumos Networks Corp
LMOS
| $644K | ﹤0.01% |
+42,199
| New | +$711K |
|
1835
PUT
Kimberly-Clark
KMB
$37B
| $643K | ﹤0.01% |
+6,000
| New | +$663K |
|
1836
PUT
IBM
IBM
$218B
| $642K | ﹤0.01% |
+4,184
| New | +$635K |
|
1837
CALL
Amgen
AMGN
$240B
| $639K | ﹤0.01% |
+4,000
| New | +$630K |
|
1838
CALL
The Greenbrier Companies
GBX
$1.43B
| $638K | ﹤0.01% |
+11,000
| New | +$608K |
|
1839
CALL
Ashland
ASH
$3.38B
| $637K | ﹤0.01% |
+10,220
| New | +$619K |
|
1840
Cohu
COHU
$2.43B
| $635K | ﹤0.01% |
58,067
-20,953
| -27% | -$237K |
|
1841
Citigroup
C
$221B
| $634K | ﹤0.01% |
12,301
-761,864
| -98% | -$38.8M |
|
1842
CALL
Chord Energy
CHRD
$7.91B
| $634K | ﹤0.01% |
+44,600
| New | +$655K |
|
|
SUNS
1843
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $632K | ﹤0.01% |
39,255
-14,019
| -26% | -$221K |
|
1844
CALL
Franco-Nevada
FNV
$52.1B
| $631K | ﹤0.01% |
+13,000
| New | +$676K |
|
1845
Orion Group Holdings
ORN
$369M
| $631K | ﹤0.01% |
71,168
-39,546
| -36% | -$380K |
|
1846
Movado Group
MOV
$772M
| $626K | ﹤0.01% |
21,967
-5,584
| -20% | -$140K |
|
1847
Texas Pacific Land
TPL
$25.8B
| $625K | ﹤0.01% |
38,826
+8,253
| +27% | +$119K |
|
1848
PUT
NextEra Energy
NEE
$175B
| $624K | ﹤0.01% |
+24,000
| New | +$633K |
|
1849
Tejon Ranch
TRC
$440M
| $623K | ﹤0.01% |
+24,276
| New | +$605K |
|
|
FRM
1850
DELISTED
FURMANITE CORPORATION COM
FRM
| $623K | ﹤0.01% |
79,007
-76,526
| -49% | -$572K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.